Reduction in shock burden with catheter ablation versus escalated antiarrhythmic drug therapy: Insights from the VANISH trial

3 April 2022 (10:55 - 11:02)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Associate Professor Michelle Samuel

Allegheny Health Network, Pittsburgh (United States of America)

5 More presentations in this session

Presentation thumbnail

Multimodality planning of stereotactic radio-ablation for ventricular tachycardia. Results from the international MUSIC consortium

Professor H. Cochet (Bordeaux, FR)

Abstract Slides Video

Presentation thumbnail

Area weighted unipolar voltage to predict heart failure death in patients with ischemic cardiomyopathy and ventricular tachycardia

Mr R. Rademaker (Leiden, NL)

Abstract Slides Video

Presentation thumbnail

Electroanatomic visualization of coronary arteries: a case series to elicit safety, feasibility and diagnostic value in complex ablation procedures

Doctor B. Fries (Landau in der Pfalz, DE)

Abstract Slides Video

Presentation thumbnail

Standardizing the cardiac radioablation targeting workflow: enabling semi-automated angulation and segmentation of the heart according to the American Heart Association segmented model

Mr M. van der Ree (Amsterdam, NL)

Abstract Slides Video

Presentation thumbnail

The outcome spectrum for Dilated Cardiomyopathy and Ventricular Tachycardia: results from the prospective, multicenter, DCM-VT ablation study

Doctor A. Wijnmaalen (Leiden, NL)

Abstract Slides Video

Access the full session

Session thumbnail

News from ventricular ablation

The Event

Event poster

EHRA 2022

3 April 2022 10:55 CET

You may be interested in

Congress Session

Ventricular tachycardia ablation in challenging scenarios: case-based management strategies

Congress Session

Ventricular storm (2)

Congress Session

The storm will pass…

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources